Transcriptional Co-Regulators and Macrophage Gene Expression
Transcriptional Co-Regulators and Macrophage Gene Expression
批准号:
7096992
负责人:
Christopher K Glass
金额:
$43.3万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 2011-03-31
关键词:
cell differentiationdevelopmental geneticsgene induction /repressiongene targetinggenetically modified animalsgranulocytehematopoiesisimmunogeneticslaboratory mousemacrophagemicroarray technologynuclear receptorsperoxisome proliferator activated receptorreceptor expressionretinoid binding proteinstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Many nuclear receptors act in trans to repress transcriptional responses to signaling pathways as a central aspect of their biological functions, but the underlying mechanisms remain an important and unresolved question in development and homeostasis. Studies performed during the current funding period of this grant demonstrated that the glucocorticoid receptor (GR), the peroxisome proliferator-activated receptor y (PPAR?) and liver X receptors (LXRs) repress responses to toll-like receptor activation in a promoter-, and nuclear receptor-specific manner. The current proposal seeks to define the underlying mechanisms responsible for these specific programs of repression on a genome-wide scale. Preliminary studies indicate that PPAR? represses a subset of inflammatory response genes in macrophages by preventing the signal- dependent dissociation of NCoR co-repressor complexes. Surprisingly, this mechanism involves ligand- dependent sumoylation of the PPAR? ligand binding domain, which targets PPAR? to NCoR/HDACs co- repressor complexes on inflammatory gene promoters. The interaction of sumoylated PPAR? with NCoR/HDAC3 complexes prevents the recruitment of ubiquitylation/igS proteosome machinery that normally mediates their signal-dependent removal. Studies in Drosophila Schneider cells suggests that this sumoylation-dependent transrepression pathway is evolutionarily conserved and is utilized by both orphan and ligand-dependent nuclear receptors. Based on these observations, we propose to explore the roles of sumoylation and NCoR co-repressor complexes in nuclear receptor-dependent transrepression of innate immune responses on a genome-wide scale. Three Specific Aims are proposed. Specific Aim i will test the hypothesis that sumoylation of nuclear receptors is a broadly used mechanism in transrepression of inflammatory programs of gene expression. Specific Aim 2 will test the hypothesis that sumoylation of nuclear receptors mediates repression of inflammatory programs of gene expression by preventing co- repressor/co-activator exchange. Specific Aim 3 will test the hypothesis that the function of NCoR co- repressor complexes is modulated by the histone methyltransferase SMYDs. The results of these studies are likely to lead to new insights into the mechanisms underlying transrepression of inflammatory responses that can be exploited for development of novel therapeutic approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10683961
-
项目类别:
-
资助金额:$249.25万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10262918
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10262913
-
项目类别:
-
资助金额:$252.51万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10461064
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10461059
-
项目类别:
-
资助金额:$251.82万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10683963
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10683973
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10262915
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10461061
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:9905343
-
项目类别:
-
资助金额:$106.13万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:9752405
-
项目类别:
-
资助金额:$106.08万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:10399455
-
项目类别:
-
资助金额:$106.37万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:9081167
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:9271257
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:10495183
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8411811
-
项目类别:
-
资助金额:$129.32万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8921152
-
项目类别:
-
资助金额:$127.13万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8712212
-
项目类别:
-
资助金额:$127.46万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
PROJECT 1: SPATIOTEMPORAL GENOME ARCHITECTURE
-
批准号:8957391
-
项目类别:
-
资助金额:$51.07万
-
财政年份:2010
-
负责人:Christopher K Glass
-
依托单位:
PROJECT 1: SPATIOTEMPORAL GENOME ARCHITECTURE
-
批准号:9293325
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2010
-
负责人:Christopher K Glass
-
依托单位:
海外基金